Form D — Vivace Therapeutics, Inc.
0001630575-25-000001 · filed Mar 12, 2025
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $34,999,993
- Total sold
- $17,499,997
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Vivace Therapeutics, Inc.
- CIK
- 1630575
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1510 Fashion Island Blvd., Suite 310
San Mateo, CA 94404 - Phone
- 858-344-7499
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Shuang Qiao · Executive OfficerSan Mateo, CA Find on LinkedIn ↗
-
Edward Hu · DirectorSan Mateo, CA Find on LinkedIn ↗
-
Tim Shannon · DirectorSan Mateo, CA Find on LinkedIn ↗
-
Jun Wu · DirectorSan Mateo, CA Find on LinkedIn ↗
-
Chenguang Zhou · DirectorSan Mateo, CA Find on LinkedIn ↗
-
Jake Simson · DirectorSan Mateo, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗